1. Lipid-lowering interventions in angiographic trials;Rossouw;Am J Cardiol,1995
2. A quarter century of drug treatment of dyslipoproteinemia, with a focus on the new HMG-CoA reductase inhibitor fluvastatin;Levy;Circulation,1993
3. Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase;Blum;Am J Cardiol,1994
4. Red Book. Update. Montvale, NJ: Medical Economics Co.; April 1996.
5. Lescol® (fluvastatin sodium) Package Insert. East Hanover, NJ: Sandoz Pharmaceuticals Corp., 1994.